Clinical Trials
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 39.3% | 1.474 | Q1 | 91.7% |
| 2024 | 2.2 | Q3 | 44.6% | 1.189 | Q1 | 88.2% |
| 2023 | 2.2 | Q3 | 43.0% | 1.148 | Q1 | 88.5% |
| 2022 | 2.7 | Q3 | 46.6% | 0.981 | Q1 | 85.9% |
| 2021 | 2.6 | Q4 | 48.6% | 1.550 | Q1 | 93.5% |
| 2020 | — | — | 1.559 | Q1 | 92.9% | |
| 2019 | — | — | 1.549 | Q1 | 93.0% | |
| 2018 | — | — | 1.417 | Q1 | 91.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1740-7745
ISSN
1740-7753
region
Western Europe
coverage
2004-2026